Anterior Segment Optical Coherence Tomography Microstent Positioning
Launched by UNIVERSITY OF UTAH · Oct 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term results of glaucoma stent surgery to understand how often the stents are positioned incorrectly and how this affects eye pressure after surgery. It's specifically looking at patients who are 18 years or older and have had cataract and microstent surgery in the last two years at the Moran Eye Center. The researchers want to see if the experience level of the surgeons makes a difference in how well the stents are placed and how effectively they lower eye pressure.
If you qualify for this study, you would have a one-time visit to the clinic for an eye exam and a special imaging test called Optical Coherence Tomography (OCT). During this visit, the team will check the position of your stent and look at important eye structures. They will also review your medical history from the past two years to gather information about your care and the results of your surgery. This study is open to all adults with glaucoma who have had specific types of stents placed, but it excludes those who had their stents removed or have certain eye injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any adult glaucoma patient (age 18+) who underwent Hydrus microstent or iStent Inject placement at the Moran Eye Center.
- Exclusion Criteria:
- • Any patient who subsequently had to have their stent removed for any reason, any patient with a history of trauma to the anterior segment or reconstruction altering typical anatomy.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murray, Utah, United States
Patients applied
Trial Officials
Rachel Simpson, MD
Principal Investigator
Moran Eye Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported